1. Home
  2. BLUE vs CODA Comparison

BLUE vs CODA Comparison

Compare BLUE & CODA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLUE
  • CODA
  • Stock Information
  • Founded
  • BLUE 1992
  • CODA 1994
  • Country
  • BLUE United States
  • CODA United States
  • Employees
  • BLUE N/A
  • CODA N/A
  • Industry
  • BLUE Biotechnology: Biological Products (No Diagnostic Substances)
  • CODA Industrial Machinery/Components
  • Sector
  • BLUE Health Care
  • CODA Industrials
  • Exchange
  • BLUE Nasdaq
  • CODA Nasdaq
  • Market Cap
  • BLUE 82.2M
  • CODA 89.7M
  • IPO Year
  • BLUE 2013
  • CODA N/A
  • Fundamental
  • Price
  • BLUE $8.14
  • CODA $8.58
  • Analyst Decision
  • BLUE Hold
  • CODA Strong Buy
  • Analyst Count
  • BLUE 9
  • CODA 1
  • Target Price
  • BLUE $49.14
  • CODA $11.00
  • AVG Volume (30 Days)
  • BLUE 292.7K
  • CODA 30.3K
  • Earning Date
  • BLUE 11-14-2024
  • CODA 01-29-2025
  • Dividend Yield
  • BLUE N/A
  • CODA N/A
  • EPS Growth
  • BLUE N/A
  • CODA N/A
  • EPS
  • BLUE N/A
  • CODA 0.26
  • Revenue
  • BLUE $53,120,000.00
  • CODA $18,824,676.00
  • Revenue This Year
  • BLUE $145.88
  • CODA $8.20
  • Revenue Next Year
  • BLUE $239.89
  • CODA $18.67
  • P/E Ratio
  • BLUE N/A
  • CODA $32.92
  • Revenue Growth
  • BLUE 144.50
  • CODA N/A
  • 52 Week Low
  • BLUE $5.80
  • CODA $5.21
  • 52 Week High
  • BLUE $38.40
  • CODA $9.89
  • Technical
  • Relative Strength Index (RSI)
  • BLUE 47.80
  • CODA 53.62
  • Support Level
  • BLUE $7.96
  • CODA $8.02
  • Resistance Level
  • BLUE $8.46
  • CODA $9.00
  • Average True Range (ATR)
  • BLUE 0.68
  • CODA 0.44
  • MACD
  • BLUE -0.06
  • CODA 0.05
  • Stochastic Oscillator
  • BLUE 15.42
  • CODA 65.16

About BLUE bluebird bio Inc.

bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.

About CODA Coda Octopus Group Inc. Common stock

Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. It operates in two segments: Marine Technology Business and Marine Engineering Business. The Technology Business develops proprietary solutions for both the commercial and defense subsea market. Its solutions include hardware and software for Geophysical Systems, Motion & Positioning Systems, and Real-Time Volumetric Imaging Sonar. The Engineering Business segment provides engineering services to a range of clients in the defense markets. Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Marine Technology Business segment.

Share on Social Networks: